about
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection.CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages.Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man.Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.Ever closer to a prophylactic vaccine for HCV.Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing.Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut.Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101.Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.Targeted reconstruction of T cell receptor sequence from single cell RNA-seq links CDR3 length to T cell differentiation state.Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8+ T Cells by Persistent Viruses and Vaccines.IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction.Circulating and intrahepatic antiviral B cells are defective in hepatitis BA Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV CoinfectionAssociation Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected PatientsThe Liver as an Immunological Barrier Redefined by Single Cell AnalysisHuman Liver Memory CD8+ T Cells Use Autophagy for Tissue ResidenceSuccessful direct-acting antiviral therapy in HIV/HCV co-infected patients fails to restore circulating mucosal-associated invariant T cellsMHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans
P50
Q33769563-14AB7B0E-DBA2-4FC7-9D84-D5785B7C93F3Q34605938-2E18C332-6337-4738-8DA6-564F3E03DEEBQ36134262-DD34240A-4A97-471A-8469-D56E70FA2AC3Q36349755-1DB1556C-7351-4584-A7B9-269964DFC8B4Q36828161-4845E2F3-5FE6-4D02-996C-D5C799192170Q37089122-F3E801BE-E36D-439F-857B-E88C457D43E3Q38606604-050B5336-2AD3-48A4-A0A4-CC860FD3EE15Q38877923-813ECB01-A0E8-46B6-B9D9-E1C94E05D4C2Q38980123-CA16F15D-6ECF-4958-BFCF-D017D47A4AF2Q39866377-7D9EAFEF-ADD4-4A64-A918-13899A3EC0BFQ40291580-A89479F2-D941-4CAE-8D41-DE2445159D99Q40588780-62537082-9B3C-4535-B7A8-8A1415CA8364Q41672361-BEA23380-43D0-4F8E-BBA5-FD05CB1A6C93Q41929416-C5E0BD7D-D543-467C-8A95-1AE7FF3C5CB5Q54233122-B38A5106-10B0-46CD-A5E0-D22FE1487C49Q55081990-A1ADE0C1-BF98-466D-9EB5-28953473CC75Q58792007-2FE6B70D-2CCB-417D-9733-B8DA438A83ECQ61813267-49DFD73E-A78F-43BB-ADBD-2F380D5E6502Q90290433-C7599A56-4868-4FBC-AD35-B54692070419Q90357188-B736DE41-F22A-4693-8031-29F66D1EF7D6Q92851813-730D9711-9B18-4507-BA48-95E066D646F6Q93091820-A009CEE0-EEAE-4A60-8CA5-54FD9A5C5E8AQ96591144-363B4C85-09E3-4DE2-80C8-1F25D940D311
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Leo Swadling
@ast
Leo Swadling
@en
Leo Swadling
@es
Leo Swadling
@nl
Leo Swadling
@sl
type
label
Leo Swadling
@ast
Leo Swadling
@en
Leo Swadling
@es
Leo Swadling
@nl
Leo Swadling
@sl
prefLabel
Leo Swadling
@ast
Leo Swadling
@en
Leo Swadling
@es
Leo Swadling
@nl
Leo Swadling
@sl
P106
P21
P31
P496
0000-0002-0537-6715